GlobeNewswire Inc.··Not SpecifiedGain Therapeutics to Showcase Parkinson's Drug Progress at Major Medical Conferences
Gain Therapeutics will present Phase 1b data for Parkinson's treatment GT-02287 at major conferences, with CEO appearing at ROTH Conference on March 23, 2026.
GANXPhase 2 clinical trialParkinson's disease